Cross-sectional study shows high treatment burden in adults with polypharmacy, indicating need for targeted interventions.
High treatment burden was more common in adults with polypharmacy who were younger, had multimorbidity, poor medication knowledge, or low adherence. This should inform design of interventions addressing treatment burden.
No takes yet. Share an insight, caveat, or question.
Duncan et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: